The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / American College of Rheumatology Backs Bill to Prevent Cuts to Infusion Reimbursement

American College of Rheumatology Backs Bill to Prevent Cuts to Infusion Reimbursement

August 21, 2013 • By Richard Quinn

  • Tweet
  • Email
Print-Friendly Version / Save PDF

The ACR has endorsed a proposed law that would exempt physician-administered drugs from future Medicare sequestration.

You Might Also Like
  • The American College of Rheumatology Helps Keep Three Biologics Off the SAD List
  • American College of Rheumatology Leads Charge to Address Excessive Patient Cost Sharing
  • American College of Rheumatology (ACR) on Capitol Hill
Also By This Author
  • Rheumatologists May Not Benefit from Hike in Healthcare Spending

The proposed Cancer Patient Protection Act of 2013 (H.R. 1416) would impact Medicare beneficiaries with arthritis and cancer who “depend on drugs administered in their physician’s office to treat their diseases,” ACR President Audrey Uknis, MD, wrote to the bill’s sponsor in a recent letter of support.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“This is a big deal to rheumatologists and their patients who need physician-administered treatments,” adds Adam Cooper, ACR’s director of government affairs.

The bill, introduced in April by Rep. Renee Ellmers (R, NC), remains still mired in committee, but the ACR continues to push for its approval. Tim Laing, MD, chair of the ACR’s Government Affairs Committee, says the issue resonates with rheumatologists who already struggle to make ends meet with in-office treatments.“Office infusions are a small margin part of the practice with very large overhead,” he writes in an e-mail to The Rheumatologist. “You have to buy the drug and get reimbursed. A couple of bad debts can take out the margin for the year. So, sequester cuts a small margin by about a third—so your risk of loss increases.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Prior reimbursement for in-office treatments already often fails to cover actual costs, the ACR says. The current formula for reimbursement for Medicare Part B drugs is average sales price (ASP) plus 6%. The proposed sequestration would reduce the 6% to 4.3%. That could force some providers to stop providing the treatments, while some practices reliant on the revenue stream might even have to shut down.

Dr. Laing says that if rheumatologists stop providing the treatment, it will simply disrupt continuity of care and push patients into less cost-effective settings.

“One way to mitigate the risk is to stop doing infusions and send patients to a hospital,” Dr. Laing writes. But that’s “where charges to insurance are typically higher, which means CMS pays more for the same service.”

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Richard Quinn is a freelance writer in New Jersey.

 

Filed Under: Legislation & Advocacy Tagged With: In-office treatment, Infusions, Medicare, Sequestration

You Might Also Like:
  • The American College of Rheumatology Helps Keep Three Biologics Off the SAD List
  • American College of Rheumatology Leads Charge to Address Excessive Patient Cost Sharing
  • American College of Rheumatology (ACR) on Capitol Hill
  • American College of Rheumatology Works with AMA to Strengthen Patient Choice

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)